Payment overview · 2025
General Payments
$86.14
1 reported records · 1 companies
Healthcare provider profile · identity verified
Diane P Nowak, MD
Allopathic & Osteopathic Physicians|Family Medicine · HELENA, MT · NPI 1295723682
Verified facts
What the public records show
CMS Open Payments records show Diane P Nowak, MD received $86.14 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $86.14 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $86.14 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $86.14 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 769 | 174 |
| Atorvastatin Calcium | Atorvastatin Calcium | 696 | 154 |
| Omeprazole | Omeprazole | 515 | 123 |
| Lisinopril | Lisinopril | 347 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 320 | 84 |
| Metformin Hcl Er | Metformin Hcl | 316 | 74 |
| Carvedilol | Carvedilol | 238 | 60 |
| Losartan Potassium | Losartan Potassium | 222 | 61 |
| Gabapentin | Gabapentin | 219 | 59 |
| Furosemide | Furosemide | 217 | 45 |
| Metoprolol Succinate | Metoprolol Succinate | 215 | 56 |
| Montelukast Sodium | Montelukast Sodium | 207 | 63 |
| Trazodone Hcl | Trazodone Hcl | 206 | 48 |
| Simvastatin | Simvastatin | 196 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 180 | 41 |
| Metformin Hcl | Metformin Hcl | 178 | 47 |
| Escitalopram Oxalate | Escitalopram Oxalate | 167 | 48 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 159 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 159 | 30 |
| Eliquis | Apixaban | 132 | 25 |
| Tramadol Hcl | Tramadol Hcl | 125 | 24 |
| Buspirone Hcl | Buspirone Hcl | 119 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 111 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 103 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 101 | 26 |
| Potassium Chloride | Potassium Chloride | 99 | 25 |
| Meloxicam | Meloxicam | 97 | 26 |
| Spironolactone | Spironolactone | 97 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 91 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 82 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 81 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 79 | 14 |
| Lorazepam | Lorazepam | 78 | 17 |
| Sertraline Hcl | Sertraline Hcl | 78 | 23 |
| Trulicity | Dulaglutide | 75 | 16 |
| Ozempic | Semaglutide | 67 | suppressed |
| Irbesartan | Irbesartan | 66 | 19 |
| Famotidine | Famotidine | 65 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 64 | suppressed |
| Chlorthalidone | Chlorthalidone | 61 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 59 | 19 |
| Propranolol Hcl Er | Propranolol Hcl | 57 | 15 |
| Clonazepam | Clonazepam | 56 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 56 | 15 |
| Estradiol | Estradiol | 55 | 23 |
| Bupropion Xl | Bupropion Hcl | 54 | 15 |
| Divalproex Sodium Er | Divalproex Sodium | 52 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 52 | 16 |
| Torsemide | Torsemide | 51 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 50 | 13 |
| Alendronate Sodium | Alendronate Sodium | 49 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 48 | 11 |
| Celecoxib | Celecoxib | 46 | 15 |
| Donepezil Hcl | Donepezil Hcl | 46 | suppressed |
| Lamotrigine | Lamotrigine | 46 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 46 | suppressed |
| Xarelto | Rivaroxaban | 46 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 42 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 41 | 19 |
| Mounjaro | Tirzepatide | 41 | suppressed |
| Valsartan | Valsartan | 40 | suppressed |
| Allopurinol | Allopurinol | 39 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | suppressed |
| Atenolol | Atenolol | 37 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 15 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 36 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | suppressed |
| Methocarbamol | Methocarbamol | 32 | suppressed |
| Synthroid | Levothyroxine Sodium | 32 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 31 | 31 |
| Glimepiride | Glimepiride | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 27 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Mirtazapine | Mirtazapine | 25 | suppressed |
| Olanzapine | Olanzapine | 25 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 24 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Baclofen | Baclofen | 23 | suppressed |
| Lovastatin | Lovastatin | 22 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | suppressed |
| Alprazolam | Alprazolam | 20 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Bumetanide | Bumetanide | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 20 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 19 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Memantine Hcl | Memantine Hcl | 18 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 18 | suppressed |
| Temazepam | Temazepam | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Carbamazepine Er | Carbamazepine | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 16 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Prednisone | Prednisone | 14 | 14 |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Levetiracetam Er | Levetiracetam | 12 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Forteo | Teriparatide | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Teriparatide | Teriparatide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $86.14 · 1 records | Amgen Inc. | EVENITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error